https://www.drugtargetreview.com/home/turning-crispr-hits-into-confident-drug-discovery-decisions/2135405.article Drug Target Review en 2026-05-07T12:30:00+01:00 Turning CRISPR hits into confident drug discovery decisions Drug Discovery,High-Throughput Screening (HTS),Stem Cells,Genomics & Sequencing,Translational Science,Drug Targets,CRISPR,Organoids,Neurological disorders https://www.drugtargetreview.com/yap1-protein-found-to-drive-chemotherapy-resistance-in-small-cell-lung-cancer-after-treatment/2135390.article Drug Target Review en 2026-05-08T12:00:00+01:00 YAP1 protein found to drive chemotherapy resistance in small cell lung cancer after treatment Oncology,Biomarkers,Drug Targets,Chemotherapy,Disease Research,Cancer,Molecular Biology https://www.drugtargetreview.com/protein-modifications-found-to-control-drug-binding-and-efficacy/2135389.article Drug Target Review en 2026-05-08T09:00:00+01:00 Protein modifications found to control drug binding and efficacy Drug Discovery,Epigenetics,Oncology,Drug Targets,Medicinal Chemistry,Molecular Biology https://www.drugtargetreview.com/openbind-launches-ai-model-to-accelerate-drug-discovery/2135387.article Drug Target Review en 2026-05-07T12:00:00+01:00 OpenBind launches AI model to accelerate drug discovery Drug Discovery,High-Throughput Screening (HTS),Drug Targets,Informatics,Drug Development,Artificial Intelligence (AI),Bioinformatics,Structural Biology https://www.drugtargetreview.com/new-framework-evaluates-ai-reliability-in-immune-system-prediction/2135385.article Drug Target Review en 2026-05-07T09:00:00+01:00 New framework evaluates AI reliability in immune system prediction Drug Discovery,Immunology,Informatics,Immunotherapy,Vaccines,Immuno-oncology,Artificial Intelligence (AI),Machine Learning (ML),Cancer